Synonyms and related keywords: rhabdomyoma, benign tumor of striated muscle, neoplastic, hamartoma, cardiac rhabdomyoma, rhabdomyomatous mesenchymal hamartomas of the skin, muscle tumor
INTRODUCTION
Background: Rhabdomyoma is a lesion of striated muscle. The 2 types of rhabdomyoma are neoplastic and hamartoma. The neoplastic variety is subclassified into adult, fetal, and genital types. Hamartomas are divided into cardiac rhabdomyoma and rhabdomyomatous mesenchymal hamartomas of the skin.
Rhabdomyoma is an exceedingly rare tumor. Some investigators believe that mature striated muscle is unlikely to develop tumorous tissue. Therefore, they believe that rhabdomyoma may arise from fetal rests.
Rhabdomyoma is diagnosed most often in men aged 25-40 years. However, the so-called fetal rhabdomyoma chiefly affects boys between birth and age 3 years.
Most rhabdomyomas involve the head and neck regions. The cardiac rhabdomyoma, which is believed to be a hamartoma, usually is diagnosed in the pediatric age group.
Pathophysiology: The adult rhabdomyoma is a rare tumor. Very few cases have been reported in the literature. This tumor usually presents as a round or polypoid mass in the region of the neck. The head and neck area harbors 90% of adult rhabdomyomas and should be considered in a differential diagnosis in this region (Bjorndal, 2006). Studies in immunohistochemistry confirm that the tumors are almost totally matured neoplasms of clonal origin. The mass is usually asymptomatic. However, the mass may compress or displace the tongue, or it may cause partial obstruction of the pharynx. Consequently, the patient may experience some hoarseness, difficulty breathing, and difficulty swallowing.
The histopathology of adult rhabdomyoma is characterized by the presence of well-differentiated large cells that resemble striated muscle cells. Cross-striation has been demonstrated by phosphotungstic acid hematoxylin (PTAH), muscle specific actin, desmin, and myoglobin while dystrophin is shown to be expressed in the cell membranes. The cells are deeply eosinophilic polygonal cells with small peripherally placed nuclei and occasional intracellular vacuoles. Adult rhabdomyoma usually is localized to the oropharynx, the larynx, and the muscles of the neck.
Fetal rhabdomyoma occurs most often in the subcutaneous tissues of the head and neck in children between birth and age 3 years. The histopathology of fetal rhabdomyoma reveals the presence of a mixture of spindle-shaped cells with indistinct cytoplasm and muscle fibers, which resemble striated muscle tissue observed in intrauterine development at 7-12 weeks. The fetal rhabdomyoma is usually found in the subcutaneous tissues of the head and neck.
Genital rhabdomyoma most often involves the vagina or vulva of young or middle-aged women. Most patients are asymptomatic. However, some patients have dyspareunia. The histopathology of genital rhabdomyoma reveals a mixture of fibroblastlike cells with clusters of mature cells containing distinct cross-striations and a matrix containing varying amounts of collagen and mucoid material. The genital rhabdomyoma usually presents as a polypoid or cystlike mass involving the vulva or vagina.
Cardiac rhabdomyoma is a hamartomatous lesion that occurs most often in the pediatric age group. Cardiac rhabdomyomas typically develop in utero and are often detected on prenatal ultrasound. It usually involves the myocardium of both ventricles and the interventricular septum. Cardiac rhabdomyoma is considered a hamartomatous proliferation frequently associated with tuberous sclerosis of the brain, sebaceous adenomas, and various hamartomatous lesions of the kidney and other organs. The association of tuberous sclerosis and cardiac rhabdomyoma is important and has usually been explained by strong clinical association. Molecular evidence of this association have now been identified as the TSC2 gene missense mutation (E36; 4672 G>A, 1558 E>K TSC2) (Jozwiak, 2005).
Rhabdomyomatous mesenchymal hamartoma is usually diagnosed in male and female newborns and infants. The histopathology of rhabdomyomatous mesenchymal hamartoma of the skin reveals that the lesions are located in the subcutis and contain poorly oriented or perpendicular bundles of well-differentiated skeletal muscle with islands of fat, fibrous tissue, and occasionally proliferating nerves.
Frequency:
Mortality/Morbidity:
Race: Rhabdomyoma has been identified in all racial groups. No predilection for any particular racial group exists.
Sex: Adult rhabdomyoma has been diagnosed mostly in men. Some reports exist of cases in women. Fetal rhabdomyoma affects boys. Genital rhabdomyoma affects young and middle-aged women. Cardiac rhabdomyoma is observed in men and women. Rhabdomyomatous mesenchymal hamartoma of skin is observed in male and female newborns and infants.
Age: Adult rhabdomyoma occurs in older adults. These patients are usually older than 40 years. Fetal rhabdomyoma occurs between birth and age 3 years. Genital rhabdomyoma is observed in young and middle-aged women. Cardiac rhabdomyomas occur chiefly, but not exclusively, in the pediatric age group. Rhabdomyomatous mesenchymal hamartoma of the skin is observed in newborns and infants.
CLINICAL
History: The presenting history depends in part on the age and sex of the patient.
Physical:
Causes: Rhabdomyoma probably represents a genetic variant of striated muscle development. Drugs or environmental factors have not been identified as causes of this neoplasm.
DIFFERENTIALS
Granular Cell Tumors
Other Problems to be Considered:
Hibernoma
Reticulohistiocytoma
Tuberous sclerosis
WORKUP
Lab Studies:
Imaging Studies:
Other Tests:
Procedures:
Histologic Findings: The histopathologic findings from patients with adult rhabdomyoma are characterized by the presence of well-differentiated large cells, which resemble striated muscle cells. The cells are deeply eosinophilic polygonal cells with small, peripherally placed nuclei and occasional intracellular vacuoles. Fetal rhabdomyoma is identifiable by the presence of a mixture of spindle-shaped cells with indistinct cytoplasm and muscle fibers, which resemble striated muscle tissue seen in intrauterine development at 7-12 weeks.
Genital rhabdomyoma is made up of a mixture of fibroblastlike cells with clusters of mature cells containing distinct cross-striations and a matrix containing varying amounts of collagen and mucoid material.
Cardiac rhabdomyoma consists of cells that closely resemble embryonic cardiac muscle cells.
The histopathology of rhabdomyomatous mesenchymal hamartoma of the skin reveals that the lesions contain poorly oriented or perpendicular bundles of well-differentiated skeletal muscle with islands of fat, fibrous tissue, and occasionally proliferating nerves.
Staging:
TREATMENT
Medical Care: Patients with adult rhabdomyoma may experience progressive difficulties in breathing and swallowing. In such instances, nasal oxygen may help patients with breathing difficulties. In circumstances in which swallowing is extremely difficult, supplemental intravenous fluids may be administered until surgery is performed. Patients with cardiac rhabdomyomas should be under the care of a cardiologist.
Surgical Care:
Consultations:
Diet: Patients with adult rhabdomyoma and problems related to swallowing may need to be placed on a liquid diet.
Activity: Patients with adult rhabdomyoma who are experiencing breathing difficulties should restrict their activities until appropriate treatment can be undertaken. Patients with cardiac rhabdomyoma also must
MEDICATION
The goals of pharmacotherapy are to reduce morbidity and to prevent complications.
Drug Category: Analgesics -- Generally, the usual pain medications (eg, aspirin with codeine, acetaminophen with codeine) may be used to relieve pain. Many patients with rhabdomyomas are asymptomatic; these patients rarely require strong pain medication.Drug Name
| Aspirin 325 mg with codeine 30 mg (Empirin with Codeine) -- Provides adequate pain relief. However, discontinue aspirin several days before any surgical treatment is undertaken to prevent excessive bleeding. |
---|
Adult Dose | 1-2 tab PO q4h prn |
---|
Pediatric Dose | Not established |
---|
Contraindications | Documented hypersensitivity; liver damage; hypoprothrombinemia; vitamin K deficiency; bleeding disorders; asthma; because of association of aspirin with Reye syndrome, do not use in children (less than 16 y) with flu |
---|
Interactions | Aspirin effects may decrease with antacids and urinary alkalinizers; corticosteroids decrease salicylate serum levels; additive hypoprothrombinemic effects and increased bleeding time may occur with coadministration of anticoagulants and aspirin; aspirin may antagonize uricosuric effects of probenecid and increase toxicity of phenytoin and valproic acid; aspirin dosages >2 g/d may potentiate glucose-lowering effect of sulfonylurea drugs Toxicity of codeine increases with concurrent administration of tricyclic antidepressants, MAOIs, neuromuscular blockers, CNS depressants, phenothiazines, and narcotic analgesics |
---|
Pregnancy | D - Unsafe in pregnancy |
---|
Precautions | Patients scheduled for surgery should discontinue use of aspirin several days before surgery is performed (aspirin can cause bleeding problems); aspirin may cause transient decrease in renal function and aggravate chronic kidney disease; avoid use in patients with severe anemia, history of blood coagulation defects, or those who are taking anticoagulants Codeine may depress hypoxic ventilatory rate and respiratory drive during sleep |
---|
Drug Name
| Acetaminophen 300 mg with codeine 15 mg (Tylenol #2) -- Indicated for the treatment of mild to moderate pain. Acetaminophen can be used safely before surgery. |
---|
Adult Dose | 1-2 tab PO q4h prn |
---|
Pediatric Dose | Not established |
---|
Contraindications | Documented hypersensitivity |
---|
Interactions | Toxicity of codeine increases with CNS depressants, tricyclic antidepressants, MAOIs, neuromuscular blockers, CNS depressants, phenothiazines, and narcotic analgesics Rifampin can reduce analgesic effects of acetaminophen; coadministration with barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity of acetaminophen |
---|
Pregnancy | C - Safety for use during pregnancy has not been established. |
---|
Precautions | Caution in patients who are dependent on opiates because this substitution may result in acute opiate-withdrawal symptoms; caution in patients with severe renal or hepatic dysfunction Hepatotoxicity with acetaminophen possible in those with long-term alcoholism following various dose levels; severe or recurrent pain or high or continued fever may indicate a serious illness; acetaminophen is contained in many OTC products, and combined use with these products may result in cumulative acetaminophen doses and exceed recommended maximum dose |
---|
Drug Name
| Acetaminophen (Tylenol, Feverall, Tempra) -- DOC for pain in patients with documented hypersensitivity to aspirin or NSAIDs, with upper GI disease, or who are taking oral anticoagulants. |
---|
Adult Dose | 325-650 mg PO q4-6h or 1000 mg PO tid/qid; not to exceed 4 g/d |
---|
Pediatric Dose | less than 12 years: 10-15 mg/kg/dose PO q4-6h prn; not to exceed 2.6 g/d
>12 years: 325-650 mg PO q4h; not to exceed 4 g/d |
---|
Contraindications | Documented hypersensitivity; known G-6-PD deficiency |
---|
Interactions | Rifampin can reduce analgesic effects of acetaminophen; coadministration with barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity |
---|
Pregnancy | B - Usually safe but benefits must outweigh the risks. |
---|
Precautions | Hepatotoxicity possible in long-term alcoholics following various dose levels; severe or recurrent pain or high or continued fever may indicate a serious illness; acetaminophen is contained in many OTC products, and combined use with these products may result in cumulative acetaminophen doses exceeding recommended maximum dose |
---|
Drug Name
| Oxycodone and acetaminophen (Percocet, Tylox) -- Drug combination indicated for the relief of moderate to severe pain. |
---|
Adult Dose | 1-2 tab or cap PO q4-6h prn pain |
---|
Pediatric Dose | 0.05-0.15 mg/kg/dose oxycodone PO, not to exceed 5 mg/dose of oxycodone, PO q4-6h prn |
---|
Contraindications | Documented hypersensitivity |
---|
Interactions | Phenothiazines may decrease analgesic effects of this medication; toxicity increases with coadministration of either CNS depressants or tricyclic antidepressants |
---|
Pregnancy | C - Safety for use during pregnancy has not been established. |
---|
Precautions | Duration of action may increase in elderly persons; be aware of total daily dose of acetaminophen patient is receiving; do not exceed 4 g/d of acetaminophen, higher doses may cause liver toxicity |
---|
FOLLOW-UP
Further Inpatient Care:
Further Outpatient Care:
In/Out Patient Meds:
Deterrence/Prevention:
Complications:
Prognosis:
Patient Education:
MISCELLANEOUS
Medical/Legal Pitfalls:
Special Concerns:
No comments:
Post a Comment